Coordinated Care to Optimize Treatment in Patients With Diabetes and Cardiovascular Disease, Panitumumab vs Bevacizumab Added to Chemotherapy for Metastatic Colorectal Cancer, USPSTF Recommendation on Screening for Skin Cancer, and more
Release Date:
Editor’s Summary by Kirsten Bibbins-Domingo, PhD, MD, MAS, Editor in Chief of JAMA, the Journal of the American Medical Association, for the April 18, 2023, issue. Related Content: Audio Highlights
Coordinated Care to Optimize Treatment in Patients With Diabetes and Cardiovascular Disease, Panitumumab vs Bevacizumab Added to Chemotherapy for Metastatic Colorectal Cancer, USPSTF Recommendation on Screening for Skin Cancer, and more